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Background: abitual snoring and elevated high-sensitive C-reactive protein (HsCRP) have both
been associated with increased risk of cardiovascular disease. However, snoring and HsCRP are
elevated in obese states which may thus be the primary determinant of both. We therefore
investigated whether snoring may mediate the increased vascular risk directly through
increased inflammation as indicated by HsCRP levels or if other determinants predominated
in a large older Chinese population.
Methods: A total of 2508 males and 5709 females aged 50e85 years received a medical check-
up including measurement of blood pressure, obesity indices, fasting total, LDL-, HDL-choles-
terol, triglycerides, glucose and HsCRP. Information on self-reported snoring status was
collected by standardized interview.
Results: The age-adjusted geometric mean HsCRP concentrations increased significantly
with higher snoring frequency in both genders (linear trend, pZ 0.02 for men and
p< 0.001 for women), but the association was no longer significant after controlling for
waist and BMI. Furthermore, HsCRP levels were not significantly associated with snoring
frequency groups stratified by BMI/waist quintiles in both genders, except for the 4th waist
quintile in men. No interaction was observed between snoring and BMI/waist on HsCRP
levels. The multivariate analysis showed that, in both genders, obesity, but not HsCRP,
was associated with snoring.2819 9287; fax: þ852 2855 9528.
u.hk (T.H. Lam).
0 Elsevier Ltd. All rights reserved.
Obesity, high-sensitive C-reactive protein and snoring 1751Conclusions: Our results showed that snoring frequency did not have an independent effect
on inflammation after adjusting for adiposity, and may thus contribute to vascular disease
through alternative mechanisms.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Inflammation is thought to play a key role in atherogenesis,
the underlying pathophysiology of most vascular diseases
including coronary artery disease and ischaemic stroke.1
This realization has lead to increasing interest in studying
inflammatory markers to assess risk of vascular disease.
High-sensitive C-reactive protein (HsCRP), for which the
assay is sensitive, reproducible, internationally standard-
ized, FDA-approved and widely available, is one of the most
promising biomarkers. HsCRP is strongly associated with
components of the metabolic syndrome2 and has been
reported to be a valuable predictor for future cardiovas-
cular diseases in more than 20 prospective cohorts.3
Sleep-disordered breathing (SDB) describes a spectrum
of conditions ranging from snoring, the most common
component, to obstructive sleep apnoea, and is recognized
as a major public health problem. Habitual snoring is
considered a precursor of sleep apnoea in those individuals
who have other risk factors for that condition,4 and both
share a similar pathophysiology. As such snoring is often
used as a surrogate for apnoeic conditions.5 Snoring and
SDB have been reported to be associated with hyperten-
sion, coronary heart disease and stroke.6e11 Although SDB is
highly correlated with obesity, some studies showed the
association with vascular disease was independent of the
effects of adiposity.7e9 HsCRP has been reported to be
associated with SDB in some studies,12e16 while others did
not observe such an association.17e20 The association
between HsCRP levels and SDB thus requires further
clarification.
We therefore investigated whether snoring may mediate
the increased vascular risk directly through increased
inflammation as indicated by HsCRP levels or if other deter-
minants predominated in a large older Chinese population.
Methods
The Guangzhou Biobank Cohort Study is a three way
collaboration between the Guangzhou People’s 12th
Hospital, Guangzhou China and the Universities of Hong
Kong, Hong Kong; and Birmingham, UK. The study aims to
examine environmental and genetic determinants of
a number of chronic diseases and plans to recruit about
30,000 older (>50 years) participants from Guangzhou in
southern China. The study has received ethical approval
from the Guangzhou Medical Ethics Committee of Chinese
Medical Association, Guangzhou, China. Details of the
participant recruitment, fasting biochemical and anthro-
pometric measurements have been described
elsewhere.2,21,22
Briefly, there were three phases for participant
recruitment for the Guangzhou Biobank Cohort Study.Around 10,000 participants were recruited in each phase.
The first phase recruitment of 10,413 participants was
completed in November 2004. High-sensitive CRP (HsCRP)
was measured in the hospital laboratory for the all partic-
ipants recruited in the first phase. HsCRP was no longer
available for the participants recruited in the second and
third phases due to the limited resources. Two questions
about snoring habit derived from the Sleep Habit Ques-
tionnaire of the ‘Sleep Heart Health Study’ were used in the
standardized interview for collecting snoring information23:
(1) Have you ever snored (now or at any time in the past)?
(2) How often do you snore now? Validation of the ques-
tionnaire was performed six months into recruitment by
recalling 200 randomly selected participants for re-inter-
view. Kappa values were: self-reported snoring (0.67),
smoking (0.96 and 0.88 for the two questions on smoking
status), drinking (0.60), and education (0.90). For the
measurement of the HsCRP (BioSystems SA, Costa Brava 30,
Barcelona, Spain), a latex agglutination turbidimetric test
with a detection limit of 0.06 mg/l was used. The intra-
assay CV at 4.9 mg/l was 4.4% (nZ 10), whereas the inter-
assay CV at that concentration was 11.8% (nZ 8). The
standards (Seronorm, CRP liquid, Sero, Billingstad, Norway)
are traceable to the European Union’s Institute for Refer-
ence Materials and Measurements (IRMM) IFCC/BCR/CAP
Certified Reference Material 470 (CRM 470). The value for
the CRM 470 was assigned with high precision from the WHO
1st International Reference Preparation for C-Reactive
Protein Immunoassay (IRP 85/506).2 We also collected
information describing the use of medications for the
treatment of major vascular disease risk factors.
The baseline data of the 10,413 participants recruited in
the first phase of the Guangzhou Biobank Study were used
in the present study. Among them, 8325 (80.0%) were able
to report whether they snored and 23 participants were not
available for HsCRP concentration. Given CRP is an
inflammatory marker which may increases sharply by
infectious disease and a cut-off value of 17 mg/l had high
sensitivity and specificity for distinguishing between
infected and non-infected disease,21,24 we further excluded
85 participants with HsCRP level of 17 mg/l or above.
A total of 8217 participants with completed information on
snoring and HsCRP concentration were included in this
cross-sectional analysis.
All statistical analyses were performed using SAS v. 9.13
(SAS Institute, Cary, NC, USA). The participants were
categorized into the following groups according to their
snoring frequency: never, 2 times or less per week, 3e4
times per week, and 5e7 times per week. Fasting triglyc-
eride, glucose and HsCRP levels had skewed distributions
and therefore their geometric means were presented, and
natural logarithm values were used for analyses. PROC
LOESS, which employs a locally weighted regression tech-
nique (loess), was used to illustrate the curvilinear
1752 X.Q. Lao et al.relationships between BMI/waist and logarithm trans-
formed HsCRP concentration.25 Analysis of covariance was
used for calculating and comparing the adjusted HsCRP
means, and assessing the linear trend across the snoring
frequency groups, stratified by BMI and waist circumfer-
ence. The analyses adjusted for the following confounders,
age (years), body mass index (kg/m2), waist circumference
(cm), education (less than or equal to primary schooling,
greater than primary schooling), medication on cardiovas-
cular disease (yes or no), smoking (never, former and
current), drinking (never, former and current), physical
activity (inactive, minimally active and regular activity),26
blood pressure (systolic and diastolic, mmHg), total
cholesterol (mmol/l), LDL-cholesterol (mmol/l), triglyc-
eride (mmol/l), glucose (mmol/l) and the month of the
blood assay.27Results
A total of 2508 males and 5709 females were included in the
analyses. In men, there were 1029 (41.0%), 554 (22.1%), 416
(16.6%) and 509 (20.3%) who did not snore, snored 2 times
or less per week, 3e4 times per week and 5e7 times per
week, respectively. In women, the corresponding figures
were 2981 (52.2%), 1151 (20.2%), 819 (14.4%) and 758
(13.3%). The prevalence of snoring in men was significantly
higher than that in women (p< 0.001). Tables 1 and 2 show
that those who snored were more educated than the non-
snorers in both genders. There were no significant associ-
ations for snoring frequency with smoking, drinking and
physical activity. Vascular risk factors including lipids,
glucose, blood pressure, obesity indices and the prevalence
of medication on cardiovascular disease increased with
higher snoring frequency in both genders, except for HDL-





Age (years) 66.8 (66.5,67.2) 65.9 (65.
Education (>primary school %) 64.0 (61.0,66.9) 71.5 (67.
Smoking (ever %) 56.8 (53.7,59.8) 54.5 (50.
Drinking (ever %) 71.5 (68.6,74.1) 74.2 (70.
Physical activity (regular %) 58.5 (55.4,61.4) 61.4 (57.
Body mass index (kg/m2) 22.7 (22.5,22.9) 23.7 (23.
Waist circumference (cm) 81.0 (80.4,81.5) 83.3 (82.
Systolic blood pressure (mmHg) 133 (132,134) 136 (134
Diastolic blood pressure (mmHg) 76 (75,77) 77 (76,
Glucose (mmol/l)a 5.75 (5.68,5.81) 5.83 (5.7
Total cholesterol (mmol/l) 5.45 (5.38,5.52) 5.53 (5.4
LDL-cholesterol (mmol/l) 2.81 (2.77,2.84) 2.84 (2.7
HDL-cholesterol (mmol/l) 1.57 (1.55,1.60) 1.55 (1.5
Triglyceride (mmol/l)a 1.27 (1.23,1.31) 1.29 (1.2
HsCRP (mg/l)a 2.47 (2.34,2.61) 2.54 (2.3
Medication on CVD (%) 29.2 (26.8,31.8) 32.4 (30.
Values are means (95% confidence interval) and prevalence (95% confi
a Geometric means.Figs. 1 and 2 show the loess curves that the logarithmi-
cally transformed HsCRP concentrations increased with
higher BMI and waist circumference in both genders. Age-
adjusted geometric HsCRP means increased significantly
with higher snoring frequency in both genders (pZ 0.018
for men and p< 0.001 for women for linear trend, Tables 1
and 2), and the means were different among 4 groups of
snoring in women (pZ 0.077 for men and pZ 0.0004 for
women). However, after adjustment for waist circumfer-
ence and BMI, there was no significantly increased linear
trend across the 4 groups (pZ 0.25 for men, and pZ 0.22
for women) and the means were not significantly difference
among the 4 groups (pZ 0.46 for men and pZ 0.45 for
women). There were no interaction effects on CRP levels
between snoring frequency and BMI/waist circumference
(for BMI quintile and snoring frequency, pZ 0.64 in men
and pZ 0.66 in women; for waist quintile and snoring
frequency, pZ 0.60 in men and pZ 0.91 in women).
Table 3 shows that there were no significant increased
linear trends of age-adjusted mean HsCRP levels with
increasing snoring frequency, and the means were not
significantly different among the 4 groups in each waist
circumference quintile in both genders except for the 4th
quintile in men. However, HsCRP levels increased with
increasing waist circumference within each snoring
frequency (p< 0.001 for women; p< 0.05 for men in two
groups). The results were similar after further adjustment
for education, smoking, drinking, physical activity, blood
pressure, cholesterol, LDL-cholesterol, triglyceride,
glucose and the month of blood assay (data not shown).
Table 4 shows no significantly increased linear trends of
HsCRPandno significant differencewith snoring frequency in
each BMI quintile in each gender, but HsCRP increased with
increasing BMI within each snoring frequency (p< 0.001 for
women and for 2 groups of men). Further adjustment as




4,66.4) 65.5 (65.0,66.1) 65.9 (65.3,66.4) <0.001
6,75.1) 71.7 (67.2,75.9) 71.5 (67.4,75.3) 0.003
4,58.6) 58.8 (54.0,63.5) 57.1 (52.8,61.3) 0.81
4,77.7) 73.6 (69.2,77.6) 69.7 (65.6,73.6) 0.55
3,65.4) 56.0 (51.2,60.7) 55.4 (51.1,59.7) 0.11
4,23.9) 24.2 (23.9,24.5) 24.6 (24.3,24.9) <0.001
5,84.0) 84.4 (83.5,85.2) 85.8 (85.0,86.6) <0.001
,138) 138 (136,140) 139 (137,140) <0.001
78) 78 (77,79) 79 (78,80) <0.001
4,5.92) 5.79 (5.68,5.89) 5.94 (5.84,6.04) 0.004
5,5.62) 5.62 (5.52,5.73) 5.63 (5.54,5.73) <0.001
9,2.89) 2.86 (2.80,2.92) 2.90 (2.85,2.95) 0.004
2,1.58) 1.57 (1.53,1.60) 1.58 (1.55,1.61) 0.91
3,1.35) 1.38 (1.32,1.46) 1.45 (1.39,1.52) <0.001
6,2.73) 2.77 (2.55,3.02) 2.71 (2.51,2.92) 0.02
5,34.3) 36.2 (33.9,38.5) 40.8 (37.2,44.5) <0.001
dence interval). All values were adjusted for age except for age.
Table 2 Age-adjusted demographic, biochemical and anthropometric parameters with increasing frequency of snoring in
Chinese women.
Snoring frequency p for trend
Never 2/week 3e4/week 5e7/week
n 2981 1151 819 758
Age (years) 64.3 (64.1,64.6) 63.4 (63.0,63.7) 63.7 (63.3,64.1) 63.4 (63.0,63.9) <0.001
Education (>primary school %) 40.1 (38.3,41.9) 49.7 (46.7,52.7) 46.9 (43.4,50.4) 46.7 (43.1,50.4) 0.001
Smoking (ever %) 5.0 (4.2,5.8) 3.9 (3.0,5.2) 4.1 (2.9,5.6) 3.2 (2.2,4.6) 0.06
Drinking (ever %) 34.4 (32.7,36.1) 39.0 (36.2,41.8) 36.2 (33.0,39.6) 37.2 (33.8,40.7) 0.14
Physical activity (regular %) 65.7 (64.0,67.4) 66.6 (63.8,69.3) 65.0 (61.6,68.1) 62.6 (59.1,66.0) 0.07
Body mass index (kg/m2) 23.2 (23.1,23.4) 24.2 (24.0,24.4) 24.7 (24.5,24.9) 25.4 (25.1,25.6) <0.001
Waist circumference (cm) 78.3 (78.0,78.6) 80.5 (80.0,81.0) 81.3 (80.8,81.9) 83.0 (82.4,83.6) <0.001
Systolic blood pressure (mmHg) 133 (132,134) 134 (133,135) 135 (134,137) 137 (135,138) <0.001
Diastolic blood pressure (mmHg) 74 (73,74) 74 (74,75) 75 (74,76) 76 (75,77) <0.001
Glucose (mmol/l)a 5.83 (5.79,5.88) 5.89 (5.82,5.97) 5.94 (5.85,6.03) 6.02 (5.93,6.12) <0.001
Total cholesterol (mmol/l) 5.95 (5.91.5.99) 5.88 (5.82.5.95) 6.04 (5.96.6.12) 6.05 (5.97.6.13) 0.01
LDL-cholesterol (mmol/l) 3.07 (3.04.3.09) 3.05 (3.01,3.08) 3.07 (3.03,3.12) 3.16 (3.11,3.20) 0.006
HDL-cholesterol (mmol/l) 1.75 (1.73,1.76) 1.73 (1.71,1.75) 1.70 (1.68,1.73) 1.74 (1.72,1.75) 0.12
Triglyceride (mmol/l)a 1.40 (1.38,1.43) 1.46 (1.42,1.50) 1.51 (1.46,1.56) 1.57 (1.51,1.62) <0.001
HsCRP (mg/l)a 2.64 (2.55,2.72) 2.72 (2.58,2.86) 2.90 (2.73,3.08) 3.03 (2.84,3.22) <0.001
Medication on CVD (%) 34.4 (32.8,36.0) 39.0 (37.7,40.3) 45.2 (43.3,47.0) 50.9 (48.0,53.8) <0.001
Values are means (95% confidence interval) and prevalence (95% confidence interval). All values were adjusted for age except for age.
a Geometric means.
Obesity, high-sensitive C-reactive protein and snoring 1753Discussion
Our results clearly show that obesity was the major
determinant of increased HsCRP in this older Chinese
population, and these results were neither confounded nor
mediated by snoring. The association of HsCRP with
snoring frequency disappeared after adjusting for BMI and
waist circumference. There were no significant associa-
tions between HsCRP and snoring frequency in each
stratified BMI or waist quintile, except for the 4th waist
circumference quintile in men (but the mean HsCRP levels
of the 4 snoring frequency groups were not significantly
different).
Obesity is a conventional risk factor for vascular diseases
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Figure 1 Association between CRP and waist by the curve
fitted using PROC LOESS.Adipocytes are critical to metabolic control, and adipo-
cyte hypertrophy is associated with molecular alterations
affecting systemic metabolism.30 Compared to adipose
tissue in lean individuals, in obese persons adipocytes show
a higher expression of proinflammatory proteins including
tumour necrosis factor-a and interleukin-6 (IL-6).30
Although the adipocytes do not secrete HsCRP directly,
the synthesis of HsCRP by the liver is predominantly regu-
lated by IL-6.31 Tumour necrosis factor-a does not directly
induce HsCRP, but can potentiate the induction of HsCRP by
stimulating the synthesis of IL-6.32 This inflammatory
response is a likely link between obesity and the subse-
quent development of vascular disease.
Although obesity is not a prerequisite for snoring, it is
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Figure 2 Association between CRP and BMI by the curve
fitted using PROC LOESS.
Table 3 Age-adjusted high-sensitive C-reactive protein levels in older Chinese with increasing snoring frequency stratified by
waist circumference.
Snoring frequency p* p for trend
Never 2/week 3e4/week 5e7/week
Male
1st quintile (52 cm) 2.25 (2.03,2.49) 2.24 (1.86,2.68) 2.26 (1.80,2.83) 2.00 (1.63,2.46) 0.79 0.42
2nd quintile (75 cm) 2.64 (2.36,2.95) 2.43 (2.09,2.84) 2.84 (2.32,3.47) 2.79 (2.32,3.36) 0.59 0.49
3rd quintile (81 cm) 2.46 (2.16,2.81) 2.53 (2.16,2.97) 2.72 (2.25,3.28) 2.19 (1.80,2.65) 0.45 0.60
4th quintile (85.5 cm) 2.54 (2.24,2.87) 2.79 (2.38,3.29) 2.98 (2.52,3.54) 3.13 (2.69,3.63) 0.17 0.027
5th quintile (90e126 cm) 2.62 (2.24,3.05) 2.75 (2.32,3.26) 2.96 (2.48,3.54) 3.10 (2.67,3.59) 0.44 0.10
p for trend 0.16 0.039 0.063 <0.001
Female
1st quintile (54 cm) 2.19 (2.05,2.33) 2.15 (1.90,2.44) 2.26 (1.92,2.67) 2.50 (2.06,3.03) 0.58 0.27
2nd quintile (72.5 cm) 2.59 (2.43,2.77) 2.35 (2.11,2.62) 2.69 (2.37,3.05) 2.62 (2.23,3.09) 0.37 0.87
3rd quintile (77.5 cm) 2.63 (2.45,2.82) 2.75 (2.46,3.07) 2.95 (2.59,3.35) 2.65 (2.31,3.04) 0.48 0.45
4th quintile (82 cm) 2.96 (2.73,3.20) 3.07 (2.73,3.46) 3.06 (2.67,3.50) 3.21 (2.82,3.65) 0.75 0.30
5th quintile (87e116 cm) 3.31 (3.05,3.59) 3.36 (3.02,3.75) 3.41 (3.00,3.86) 3.71 (3.31,4.16) 0.45 0.13
p for trend <0.001 <0.001 <0.001 <0.001
*p Value for age-adjusted mean comparison among the 4 snoring frequency groups.
1754 X.Q. Lao et al.frequency in our participants,6 as has been observed in
other studies.9,10,33 The mechanism underlying the associ-
ation of snoring with vascular disease remains uncertain.
Indeed, people who snore have increased prevalence of
a number of metabolic abnormalities such as hypertension,
insulin resistance and obesity.6,9,10,33,35 However, it is
unclear whether snoring per se is directly associated with
vascular disease, or whether concomitant changes in
common precursors result in both increases in snoring and
vascular disease. Some studies have found that snoring was
associated with the risk of vascular disease even after
control of BMI and other potential confounders,6,8,9,34 but





1st quintile (15.15 kg/m2) 2.30 (2.07,2.56) 2.16 (1.77,2.
2nd quintile (20.91 kg/m2) 2.47 (2.19,2.78) 2.41 (2.03,2.
3rd quintile (22.63 kg/m2) 2.52 (2.24,2.83) 2.62 (2.28,3.
4th quintile (24.30 kg/m2) 2.47 (2.16,2.83) 2.47 (2.12,2.
5th quintile
(26.18e44.44 kg/m2)
2.79 (2.42,3.21) 3.04 (2.57,3.
p for trend 0.069 0.0089
Female
1st quintile (13.84 kg/m2) 2.24 (2.10,2.39) 2.07 (1.83,2.
2nd quintile (21.09 kg/m2) 2.41 (2.26,2.58) 2.59 (2.30,2.
3rd quintile (22.97 kg/m2) 2.60 (2.42,2.79) 2.62 (2.32,2.
4th quintile (24.61 kg/m2) 3.00 (2.78,3.24) 3.07 (2.75,3.
5th quintile
(26.64e42.30 kg/m2)
3.52 (3.26,3.80) 3.25 (2.95,3.
p for trend <0.001 <0.001
*p value for age-adjusted mean comparison among the 4 snoring freqfor these effects.36 A study showed that habitual snoring
was an important predisposing factor in future hyperten-
sion even for non-obese adults (BMI <27.5 kg/m2).7
However, BMI and waist circumference increased with
higher frequency of snoring even for non-obese people in
the present study (Figs. 1 and 2) and it is well-known that
obesity cut-off points are arbitrary along a continuum of
increasing risk with increasing adiposity.37
The advantages of our study include the large sample
size which enabled us to analyse the data separately for
women and men, and to stratify by BMI and waist
circumference into quintiles to assess the potential effect
modifying as well as confounding roles of obesity on theolder Chinese with increasing snoring frequency stratified by
p* p for trend
3e4/week 5e7/week
64) 2.20 (1.74,2.78) 2.26 (1.82,2.80) 0.95 0.74
87) 2.16 (1.73,2.69) 2.49 (2.03,3.06) 0.74 0.72
01) 3.28 (2.74,3.92) 2.51 (2.11,2.98) 0.088 0.41
89) 2.73 (2.30,3.25) 2.60 (2.22,3.05) 0.80 0.47
59) 3.34 (2.84,3.93) 3.29 (2.88,3.76) 0.29 0.072
<0.001 <0.001
34) 2.23 (1.88,2.66) 2.26 (1.82,2.80) 0.73 0.83
91) 2.51 (2.17,2.90) 2.48 (2.08,2.95) 0.79 0.57
95) 2.97 (2.60,3.40) 2.60 (2.25,3.00) 0.37 0.44
43) 2.96 (2.62,3.34) 3.05 (2.69,3.46) 0.97 0.92
58) 3.56 (3.18,3.98) 3.92 (3.55,4.34) 0.070 0.083
<0.001 <0.001
uency groups.
Obesity, high-sensitive C-reactive protein and snoring 1755association between serum HsCRP concentration with
snoring. Serum HsCRP concentrations have been shown to
differ between genders and ethnic populations.38,39
Knowledge of gender is a must for interpretation of
HsCRP levels. Gender-specific analyses can remove con-
founding of gender when examining other factors associ-
ated with HsCRP concentrations.40 Similarly, stratified
analysis of BMI and waist circumference can better assess
the role of obesity on the association between HsCRP
concentration and snoring. Previous reports describing
the association between sleep-disordered breathing and
HsCRP are conflicting.12e20 BMI was generally controlled
for as an indicator of obesity in most of these studies,
but BMI may not fully indicate central or visceral fat
deposition, which is a key determinant of the metabolic
syndrome. Adiposity and HsCRP are so strongly related
that complete adjustment may not be achieved by such
statistical approaches.41 However, there are several
limitations for the present study. We did not assess for
obstructive sleep apnoea or hypopnoea in our partici-
pants. Therefore we could not distinguish the effect of
sleep apnoea or hypopnoea from snoring. In addition, the
participants included in the present study were ranged
from 50 to 85 years old. There were studies reporting
a more pronounced effect of sleep-disordered breathing
on cardiovascular consequences and mortality in younger
subjects as compared to older populations.42,43 Additional
research is needed to study the role of obesity on the
association between snoring and HsCRP among young
population. Another limitation is that we did not collect
the information on the duration of snoring. Therefore we
could not able to assess the impact of duration of snoring
on HsCRP levels. Lastly, snoring frequency in present
study was self-reported and not validated by bed partner,
although this approach is commonly used in epidemio-
logical studies.
In summary, our results showed that snoring frequency
did not have an independent effect on HsCRP levels after
adjusting for body mass index and waist circumference, and
may thus contribute to vascular disease through alternative
mechanisms.
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